Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Sysmex ( (JP:6869) ) is now available.
Sysmex Corporation has announced the introduction of a performance-linked stock compensation plan for its Managing Board members and Executive Officers, excluding certain directors and nonresidents of Japan. This plan aims to align the interests of the board members with shareholders by linking their compensation to the company’s performance and stock value, thereby encouraging them to contribute to the company’s long-term growth. The plan will replace the current officer shareholding association system and stock options, pending approval at the upcoming Shareholders’ Meeting. The new compensation structure will include fixed compensation, performance-linked compensation, and stock-based compensation, with oversight from a Compensation Committee to ensure independence and accountability.
The most recent analyst rating on (JP:6869) stock is a Buy with a Yen3500.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation is a company based in Kobe, Japan, operating in the healthcare industry. It specializes in the development and production of diagnostic systems and reagents, focusing on hematology, urinalysis, and hemostasis. The company is known for its innovative solutions in laboratory diagnostics.
Average Trading Volume: 1,229,012
Technical Sentiment Signal: Sell
Current Market Cap: Yen1646.3B
Find detailed analytics on 6869 stock on TipRanks’ Stock Analysis page.